Report Detail

Other Global In Situ Hybridization (ISH) Market Size, Status and Forecast 2019-2025

  • RnM3475570
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 96 pages
  • |
  • QYResearch
  • |
  • Other

Global In Situ Hybridization (ISH) Market Size, Status and Forecast 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global In Situ Hybridization (ISH) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Instruments
      • 1.4.3 Kits & Probes
      • 1.4.4 Software
      • 1.4.5 Services
    • 1.5 Market by Application
      • 1.5.1 Global In Situ Hybridization (ISH) Market Share by Application (2014-2025)
      • 1.5.2 Cancer
      • 1.5.3 Cytogenetics
      • 1.5.4 Developmental Biology
      • 1.5.5 Infectious Diseases
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 In Situ Hybridization (ISH) Market Size
    • 2.2 In Situ Hybridization (ISH) Growth Trends by Regions
      • 2.2.1 In Situ Hybridization (ISH) Market Size by Regions (2014-2025)
      • 2.2.2 In Situ Hybridization (ISH) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 In Situ Hybridization (ISH) Market Size by Manufacturers
      • 3.1.1 Global In Situ Hybridization (ISH) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global In Situ Hybridization (ISH) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global In Situ Hybridization (ISH) Market Concentration Ratio (CR5 and HHI)
    • 3.2 In Situ Hybridization (ISH) Key Players Head office and Area Served
    • 3.3 Key Players In Situ Hybridization (ISH) Product/Solution/Service
    • 3.4 Date of Enter into In Situ Hybridization (ISH) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global In Situ Hybridization (ISH) Market Size by Type (2014-2019)
    • 4.2 Global In Situ Hybridization (ISH) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States In Situ Hybridization (ISH) Market Size (2014-2019)
    • 5.2 In Situ Hybridization (ISH) Key Players in United States
    • 5.3 United States In Situ Hybridization (ISH) Market Size by Type
    • 5.4 United States In Situ Hybridization (ISH) Market Size by Application

    6 Europe

    • 6.1 Europe In Situ Hybridization (ISH) Market Size (2014-2019)
    • 6.2 In Situ Hybridization (ISH) Key Players in Europe
    • 6.3 Europe In Situ Hybridization (ISH) Market Size by Type
    • 6.4 Europe In Situ Hybridization (ISH) Market Size by Application

    7 China

    • 7.1 China In Situ Hybridization (ISH) Market Size (2014-2019)
    • 7.2 In Situ Hybridization (ISH) Key Players in China
    • 7.3 China In Situ Hybridization (ISH) Market Size by Type
    • 7.4 China In Situ Hybridization (ISH) Market Size by Application

    8 Japan

    • 8.1 Japan In Situ Hybridization (ISH) Market Size (2014-2019)
    • 8.2 In Situ Hybridization (ISH) Key Players in Japan
    • 8.3 Japan In Situ Hybridization (ISH) Market Size by Type
    • 8.4 Japan In Situ Hybridization (ISH) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia In Situ Hybridization (ISH) Market Size (2014-2019)
    • 9.2 In Situ Hybridization (ISH) Key Players in Southeast Asia
    • 9.3 Southeast Asia In Situ Hybridization (ISH) Market Size by Type
    • 9.4 Southeast Asia In Situ Hybridization (ISH) Market Size by Application

    10 India

    • 10.1 India In Situ Hybridization (ISH) Market Size (2014-2019)
    • 10.2 In Situ Hybridization (ISH) Key Players in India
    • 10.3 India In Situ Hybridization (ISH) Market Size by Type
    • 10.4 India In Situ Hybridization (ISH) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America In Situ Hybridization (ISH) Market Size (2014-2019)
    • 11.2 In Situ Hybridization (ISH) Key Players in Central & South America
    • 11.3 Central & South America In Situ Hybridization (ISH) Market Size by Type
    • 11.4 Central & South America In Situ Hybridization (ISH) Market Size by Application

    12 International Players Profiles

    • 12.1 Thermo Fisher Scientific
      • 12.1.1 Thermo Fisher Scientific Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 In Situ Hybridization (ISH) Introduction
      • 12.1.4 Thermo Fisher Scientific Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.1.5 Thermo Fisher Scientific Recent Development
    • 12.2 Leica BiosystemsNussloch GmbH
      • 12.2.1 Leica BiosystemsNussloch GmbH Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 In Situ Hybridization (ISH) Introduction
      • 12.2.4 Leica BiosystemsNussloch GmbH Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.2.5 Leica BiosystemsNussloch GmbH Recent Development
    • 12.3 BIOVIEW
      • 12.3.1 BIOVIEW Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 In Situ Hybridization (ISH) Introduction
      • 12.3.4 BIOVIEW Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.3.5 BIOVIEW Recent Development
    • 12.4 Agilent Technologies
      • 12.4.1 Agilent Technologies Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 In Situ Hybridization (ISH) Introduction
      • 12.4.4 Agilent Technologies Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.4.5 Agilent Technologies Recent Development
    • 12.5 Merck KGaA
      • 12.5.1 Merck KGaA Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 In Situ Hybridization (ISH) Introduction
      • 12.5.4 Merck KGaA Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.5.5 Merck KGaA Recent Development
    • 12.6 PerkinElmer Inc.
      • 12.6.1 PerkinElmer Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 In Situ Hybridization (ISH) Introduction
      • 12.6.4 PerkinElmer Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.6.5 PerkinElmer Inc. Recent Development
    • 12.7 Bio-Rad Laboratories Inc.
      • 12.7.1 Bio-Rad Laboratories Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 In Situ Hybridization (ISH) Introduction
      • 12.7.4 Bio-Rad Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.7.5 Bio-Rad Laboratories Inc. Recent Development
    • 12.8 NeoGenomics Laboratories Inc.
      • 12.8.1 NeoGenomics Laboratories Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 In Situ Hybridization (ISH) Introduction
      • 12.8.4 NeoGenomics Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.8.5 NeoGenomics Laboratories Inc. Recent Development
    • 12.9 Advanced Cell Diagnostics Inc.
      • 12.9.1 Advanced Cell Diagnostics Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 In Situ Hybridization (ISH) Introduction
      • 12.9.4 Advanced Cell Diagnostics Inc. Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.9.5 Advanced Cell Diagnostics Inc. Recent Development
    • 12.10 Oxford Gene Technology
      • 12.10.1 Oxford Gene Technology Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 In Situ Hybridization (ISH) Introduction
      • 12.10.4 Oxford Gene Technology Revenue in In Situ Hybridization (ISH) Business (2014-2019)
      • 12.10.5 Oxford Gene Technology Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).
      Increase in incidence of chronic diseases, coupled with need for rapid diagnostic techniques, is contributing to the increase in adoption of ISH.
      In 2018, the global In Situ Hybridization (ISH) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global In Situ Hybridization (ISH) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In Situ Hybridization (ISH) development in United States, Europe and China.

      The key players covered in this study
      Thermo Fisher Scientific
      Leica BiosystemsNussloch GmbH
      BIOVIEW
      Agilent Technologies
      Merck KGaA
      PerkinElmer Inc.
      Bio-Rad Laboratories Inc.
      NeoGenomics Laboratories Inc.
      Advanced Cell Diagnostics Inc.
      Oxford Gene Technology

      Market segment by Type, the product can be split into
      Instruments
      Kits & Probes
      Software
      Services

      Market segment by Application, split into
      Cancer
      Cytogenetics
      Developmental Biology
      Infectious Diseases
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global In Situ Hybridization (ISH) status, future forecast, growth opportunity, key market and key players.
      To present the In Situ Hybridization (ISH) development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of In Situ Hybridization (ISH) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on In Situ Hybridization (ISH). Industry analysis & Market Report on In Situ Hybridization (ISH) is a syndicated market report, published as Global In Situ Hybridization (ISH) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of In Situ Hybridization (ISH) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,117.69
      4,676.54
      6,235.38
      3,472.34
      5,208.51
      6,944.68
      420,030.00
      630,045.00
      840,060.00
      268,557.90
      402,836.85
      537,115.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report